These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 10788684)
1. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Langendijk H; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Wouters M Radiother Oncol; 2000 Apr; 55(1):19-25. PubMed ID: 10788684 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy. Langendijk JA; Aaronson NK; ten Velde GP; de Jong JM; Muller MJ; Wouters EF Acta Oncol; 2000; 39(8):949-58. PubMed ID: 11207002 [TBL] [Abstract][Full Text] [Related]
3. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer. Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787 [TBL] [Abstract][Full Text] [Related]
4. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Slotman BJ; Wouters EF Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):847-53. PubMed ID: 12095549 [TBL] [Abstract][Full Text] [Related]
5. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy. Ozturk A; Sarihan S; Ercan I; Karadag M Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128 [TBL] [Abstract][Full Text] [Related]
6. Quality of life assessment as a predictor of survival in non-small cell lung cancer. Braun DP; Gupta D; Staren ED BMC Cancer; 2011 Aug; 11():353. PubMed ID: 21843358 [TBL] [Abstract][Full Text] [Related]
7. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383 [TBL] [Abstract][Full Text] [Related]
8. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group. Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329 [TBL] [Abstract][Full Text] [Related]
9. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764 [TBL] [Abstract][Full Text] [Related]
10. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy. Mathieu D; Campeau MP; Bahig H; Larrivée S; Vu T; Lambert L; Lavoie C; Roberge D; Doucet R; Carrier JF; Gorgos A; Fortin B; Filion E Pract Radiat Oncol; 2015; 5(4):e365-73. PubMed ID: 25680997 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review. Nguyen LN; Komaki R; Allen P; Schea RA; Milas L Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538 [TBL] [Abstract][Full Text] [Related]
12. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200 [TBL] [Abstract][Full Text] [Related]
13. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial. Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635 [TBL] [Abstract][Full Text] [Related]
14. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study. Nieto-Guerrero Gómez JM; Silva Vega GP; Cacicedo J; Delgado León BD; Herrero Rivera D; Praena Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; López Guerra JL Clin Transl Oncol; 2020 Sep; 22(9):1635-1644. PubMed ID: 32072471 [TBL] [Abstract][Full Text] [Related]
15. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer. Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935 [TBL] [Abstract][Full Text] [Related]
16. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441 [TBL] [Abstract][Full Text] [Related]
17. The association of liver function and quality of life of patients with liver cancer. Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687 [TBL] [Abstract][Full Text] [Related]
18. Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery. Barlési F; Doddoli C; Loundou A; Pillet E; Thomas P; Auquier P Eur J Cardiothorac Surg; 2006 Sep; 30(3):548-53. PubMed ID: 16860566 [TBL] [Abstract][Full Text] [Related]
19. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study. Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]